Nektar Therapeutics | NKTR - Net Income


Nektar Therapeutics reported $-44.9M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Agios Pharmaceuticals USD -99.11M 8.93M Mar/2026
ALKERMES USD 501K 66.98M Jun/2026
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Amgen USD 2.38B 556M Jun/2026
Baxter International USD 126M 141M Jun/2026
BioCryst Pharmaceuticals USD 78.4M 167.45M Jun/2026
Biogen USD 97.5M 222M Jun/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Cara Therapeutics USD -6.8M 1.28M Mar/2026
Cipla INR 7.89B 2.34B Jun/2026
Dr.Reddys Laboratories INR 4.44B 2.23B Jun/2026
Eisai JPY 18.24B 21.49B Jun/2026
Eli Lilly USD 7.1B 301M Jun/2026
Exelixis USD 212.05M 1.58M Jun/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
GlaxoSmithKline GBP 435M 1.3B Jun/2026
Grifols EUR 114.37M 34.03M Dec/2025
Halozyme Therapeutics USD 229.91M 79.86M Jun/2026
Incyte USD 585.6M 282.27M Jun/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
Karyopharm Therapeutics USD -22.39M 79.81M Mar/2026
MacroGenics USD -36.77M 22.62M Mar/2026
Merck USD -1.34B 2.9B Jun/2026
Nektar Therapeutics USD -44.9M 8.82M Mar/2026
Neurocrine Biosciences USD 144.4M 53.5M Jun/2026
Novartis USD 3.26B 108M Jun/2026
Pfizer USD -248M 2.94B Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sarepta Therapeutics USD 330.96M 743.18M Mar/2026
Takeda JPY 113.2B 137.52B Jun/2026
Teva Pharmaceutical Industries USD -576M 945M Jun/2026
Xencor USD -21.73M 107.19M Jun/2026